The CRO concept fluctuated and declined in early trading. Medicis and Yakkang Biotech fell more than 10%, and many stocks such as Baicheng Pharmaceuticals, Novizan, Betta Pharmaceuticals, Boji Pharmaceuticals, and Hongbo Pharmaceutical fell more than 6%.

Zhitongcaijing · 3d ago
The CRO concept fluctuated and declined in early trading. Medicis and Yakkang Biotech fell more than 10%, and many stocks such as Baicheng Pharmaceuticals, Novizan, Betta Pharmaceuticals, Boji Pharmaceuticals, and Hongbo Pharmaceutical fell more than 6%.